Drug Profile

Methadone - Recordati

Alternative Names: Methadone chlorhydrate AP HP; Zoryon

Latest Information Update: 19 Dec 2021

Price :

$50 ^*

Note:

Adis is an information provider. We do not sell or distribute actual drugs.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

Originator Recordati
Class Drug withdrawal therapies; Ketones; Opioid analgesics
Mechanism of Action Opioid mu receptor agonists

Orphan Drug Status

Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

No
New Molecular Entity No

Highest Development Phases

Marketed Cancer pain; Opioid-related disorders

Most Recent Events

15 Oct 2018 Methadone is still under review for Cancer pain in France (PO) (Recordati pipeline, October 2018)
16 Sep 2015 Preregistration for Cancer pain in France (PO) prior to September 2015
31 May 2014 Recordati completes the phase III EQUIMETH2 trial in Cancer pain in France (NCT01793480) (EudraCT2011-004609-26)

You need to be a logged in or subscribed to view this content

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com